Sofinnova Raises €445m To Help European Biotechs Reach Critical Mass - And SPACs Are A Welcome Innovation
Funds To Fuel Maturing Firms
Executive Summary
VC’s new fundraising is oversubscribed, reflecting growing confidence in developing European biotech sector.